http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011137029-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e5cb5c1a269e52c11cdc4172789a6e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_be9193b38171d0d49050868fa34e08fb
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36114
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-378
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-025
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-378
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-372
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-36
filingDate 2011-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a29c89ffbf693de68684b9f1775d5a0
publicationDate 2011-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2011137029-A1
titleOfInvention Delivering scheduled and unscheduled therapy without detriment to battery life or accuracy of longevity predictions
abstract A method comprises applying a first open-loop electrical signal to a neural structure at a first rate. The method also comprises applying a closed-loop electrical signal to the neural structure in response to an event detection, thus causing an overall rate at which electrical stimulation is applied to the neural structure to exceed the first rate. The method further comprises applying a second open-loop electrical signal to a neural structure at a second rate that is lower than the first rate, thus causing the overall rate to be reduced to the first rate.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10092756-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3113033-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9981132-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10124173-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3111990-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3111991-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10099056-B2
priorityDate 2010-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005131467-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009018607-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009082641-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004034880-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008027242-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID224478
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412483216
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID160896979
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452740012

Total number of triples: 33.